These two compounds are the protocol's primary force multipliers. Both are off-patent with growing anti-cancer research.
🧬 Section 3: Synergy Science — How the Compounds Work Together
This protocol is not a random collection of supplements. Each compound was selected because it amplifies others through overlapping and complementary mechanisms. The Authoritative Agents (Ivermectin and Mebendazole) are force multipliers for the entire stack.
🔗 Core Supplement Synergies
Curcumin + Piperine: Piperine inhibits hepatic and intestinal glucuronidation, increasing curcumin bioavailability by 2,000%. Without piperine, most curcumin is excreted before reaching therapeutic levels.
Quercetin + EGCG: Quercetin inhibits COMT — the enzyme that degrades EGCG in the bloodstream. This keeps EGCG active 3-4x longer, providing continuous angiogenesis suppression throughout the dosing cycle.
Resveratrol + Berberine: Both activate AMPK but through entirely different upstream mechanisms — resveratrol via SIRT1 and berberine directly. Combined AMPK activation is greater than either alone, maximizing mTOR suppression and Warburg effect disruption.
Vitamin D3 + K2: D3 dramatically increases calcium absorption; K2 (MK-7) activates osteocalcin to direct that calcium into bones instead of arteries. At 10,000 IU D3, K2 is non-negotiable. Both independently show anti-cancer activity — together they also modulate PD-L1 expression.
Lactoferrin + Zinc: Lactoferrin sequesters iron (which cancer cells need to proliferate) while zinc is the essential cofactor for p53 tumor suppressor function. Dual mineral disruption — starve cancer of iron while activating the "guardian of the genome."
Turkey Tail + Probiotics: Turkey tail PSK/PSP activate dendritic cells and train the immune system to recognize tumors. Probiotics ensure the gut microbiome (where 70% of immune activity originates) is optimized to support that immune activation. Gut dysbiosis blunts PSK/PSP efficacy.
Tocotrienols + EGCG: Both independently inhibit NF-kB — the master inflammatory transcription factor that cancer cells hijack for survival signaling. Dual NF-kB suppression from different pathway entry points creates redundant blockade.
Milk Thistle + Everything: The liver processes every compound in this protocol. Silymarin protects hepatic function at the cellular level, ensuring the protocol doesn't stress the organ it depends on for metabolism. This is why it's included — it's the protocol's insurance policy.
💊 Ivermectin — Force Multiplier Across the Stack
Ivermectin is not just another compound — it's a
systemic potentiator that makes nearly every other compound in this protocol work harder.
IVM + Curcumin: Ivermectin inhibits P-glycoprotein (P-gp) — the drug efflux pump that cancer cells use to flush out threatening compounds before they can cause damage. By blocking P-gp, IVM traps curcumin inside cancer cells at higher concentrations, dramatically increasing its apoptotic effect. (
PubMed 32871846)
IVM + EGCG: Same P-gp mechanism — EGCG is also a substrate of the P-gp efflux pump. IVM prevents cancer cells from expelling EGCG, allowing it to maintain the intracellular concentrations needed for caspase-3 activation and apoptosis.
IVM + Quercetin: IVM suppresses the Akt/mTOR survival pathway from the top (Akt inhibition) while quercetin attacks the same pathway downstream (PI3K inhibition). This pincer movement closes both the front and back doors of cancer cell survival signaling.
IVM + Berberine: Both target cancer cell energy metabolism — berberine activates AMPK to starve cancer of glucose (Warburg suppression), while IVM inhibits mitochondrial complex I, disrupting the cancer cell's backup energy production. Dual metabolic strangulation.
IVM + Resveratrol: Resveratrol activates SIRT1 to trigger autophagy in damaged cells. IVM independently induces autophagy through PAK1 inhibition. Combined autophagy activation through two independent pathways amplifies selective destruction of pre-cancerous and cancerous cells.
IVM + Vitamin D3: IVM modulates the WNT/β-catenin pathway — the same pathway that vitamin D3's active form (calcitriol) regulates for cell differentiation. Together they push cancer cells toward differentiation (becoming normal) rather than proliferation.
IVM + Turkey Tail: IVM reduces immunosuppressive regulatory T-cells in the tumor microenvironment while turkey tail PSK/PSP activate dendritic cells and cytotoxic T-cells. IVM clears the immunosuppressive shield; turkey tail sends in the attack force.
IVM + Black Seed Oil (TQ): Both compounds activate p53 through different mechanisms — IVM via PAK1 inhibition and thymoquinone via direct p53 stabilization. Dual p53 activation means cancer cells face redundant "self-destruct" signals.
IVM + Fasting: Fasting reduces circulating IGF-1 (a major cancer growth signal). IVM inhibits the Akt pathway that IGF-1 activates. The combination amplifies IGF-1 pathway suppression — fasting reduces the signal, IVM blocks the receptor response.
💊 Mebendazole — Structural Warfare Across the Stack
Mebendazole attacks cancer at the structural level — disrupting the microtubules that cancer cells need to divide. But its synergies extend far beyond that single mechanism.
MBZ + Berberine: MBZ arrests cancer cells in metaphase (they can't complete division because their microtubules are disrupted). Berberine simultaneously starves those arrested cells of glucose via AMPK/Warburg suppression. The cells can't divide AND can't eat — dual death sentence. (
PubMed 27978312)
MBZ + Curcumin: Cancer cells activate NF-kB as a survival response when their microtubules are disrupted by MBZ. Curcumin blocks NF-kB. This shuts down the cancer cell's emergency escape route — MBZ delivers the structural damage, curcumin prevents the repair response.
MBZ + EGCG: MBZ inhibits angiogenesis (new blood vessel formation to feed tumors) via VEGF suppression. EGCG independently suppresses VEGF through a different upstream pathway. Dual anti-angiogenic attack cuts off the tumor's blood supply from two directions.
MBZ + Quercetin: MBZ induces cell cycle arrest at the G2/M checkpoint. Quercetin independently induces arrest at the same checkpoint through PI3K/Akt inhibition. Redundant G2/M blockade means cancer cells that escape one mechanism are caught by the other.
MBZ + Resveratrol: Both compounds activate caspase-dependent apoptosis — MBZ through microtubule-mediated mitotic catastrophe and resveratrol through SIRT1-mediated mitochondrial pathway. Two roads to the same destination: programmed cancer cell death.
MBZ + Lactoferrin + Zinc: MBZ increases oxidative stress specifically in cancer cells. Lactoferrin sequesters iron (preventing cancer from using iron-dependent antioxidant defenses), while zinc activates p53 to push the oxidatively stressed cell toward apoptosis. Triple hit: structural damage + stripped defenses + activated self-destruct.
MBZ + Tocotrienols: MBZ disrupts microtubules from the colchicine binding site. Tocotrienols independently trigger the death receptor pathway (extrinsic apoptosis). Cancer cells face simultaneous attack from inside (structural collapse) and outside (death receptor activation).
MBZ + Milk Thistle: Critical safety synergy — MBZ is hepatically metabolized and can elevate liver enzymes at sustained 1,000mg/day dosing. Silymarin provides hepatoprotection at the cellular level, specifically protecting hepatocytes from drug-induced oxidative stress. This is why milk thistle is non-negotiable in this protocol.
MBZ + Fasting: Cancer cells under metabolic stress from fasting (glucose deprivation, reduced IGF-1) are significantly more vulnerable to MBZ's microtubule disruption. Healthy cells in a fasting state enter a protective mode (differential stress resistance) that makes them MORE resistant to MBZ — widening the therapeutic window between cancer cell damage and healthy cell protection.
⚡ IVM + MBZ Together — The Authoritative Agent Synergy
Ivermectin and Mebendazole were selected as Authoritative Agents specifically because they attack cancer from completely different angles while amplifying each other:
Complementary mechanisms: IVM targets signaling pathways (Akt/mTOR, WNT, PAK1, P-gp) while MBZ targets physical structure (microtubules, angiogenesis). Cancer cells cannot develop resistance to both simultaneously.
Blood-brain barrier: Both cross the BBB — making this protocol relevant for brain tumors and brain metastases, where most supplements cannot reach.
Multidrug resistance reversal: IVM's P-gp inhibition doesn't just help supplements — it reverses the multidrug resistance that makes cancer cells resistant to MBZ itself. IVM makes MBZ more effective.
Safety profile: Both are off-patent medications with decades of safe human use at therapeutic doses. Combined with milk thistle hepatoprotection and the 1-day-off-per-week MBZ schedule, the safety profile is manageable under clinical supervision.
Published precedent: The "Joe Tippens protocol" (fenbendazole, a close analog of mebendazole) combined with curcumin and CBD demonstrated remarkable individual case responses. This protocol replaces fenbendazole with mebendazole (better studied in humans) and builds a complete 19-compound synergistic system around it.
Probiotics + All Compounds: Gut microbiome diversity directly determines the absorption efficiency of every oral supplement in this protocol. Dysbiosis (imbalanced gut flora) can reduce curcumin, quercetin, and berberine absorption by 40-60%. Probiotics are the foundation that makes everything else work at full potency.
📖 PEER-REVIEWED: Ivermectin + Mebendazole Combined Cancer Protocol
The world's first peer-reviewed protocol combining IVM + MBZ + FBZ for cancer was published September 19, 2024 in the
Journal of Orthomolecular Medicine (Vol. 39, No. 3) by Baghli, Martinez, Makis, Marik et al. — co-authored by 16 researchers including Dr. William Makis and FLCCC's Dr. Paul Marik.
Why Two Anti-Parasitic Agents Together?
IVM (Ivermectin) and MBZ (Mebendazole) belong to completely different drug classes with complementary anti-cancer mechanisms, and antiparasitic drugs share overlapping targets with anti-tumor drugs including cyclin-dependent kinases and the tubulin/microtubule system
[PMID 34220783]:
•
IVM targets signaling — Akt/mTOR, Wnt/β-catenin, PAK1, NF-κB, STAT3, importin-β
[PMID 32971268]
•
MBZ targets structure — microtubule polymerization, angiogenesis (VEGFR2), kinases (BRAF, TNIK)
[PMID 31489501]
•
IVM reverses drug resistance — inhibits P-glycoprotein efflux pumps (MDR1) making cancer cells more sensitive to MBZ and all other agents
[PMID 33493461]
•
Both cross the blood-brain barrier — MBZ especially has BBB penetration, relevant for brain tumors
[PMID 36078189]
•
IVM converts cold tumors hot — induces immunogenic cell death (ICD), converts immunologically cold tumors to hot via T-cell infiltration; combination with anti-PD1 achieves synergistic complete tumor regression (p<0.001)
[PMID 33649334]
•
MBZ polarizes macrophages to M1 — activates anti-tumor immune phenotype while reducing immunosuppression
[PMID 31489501]
•
Together they target cancer stem cells (CSCs) — the 2024 Baghli protocol specifically addresses CSC elimination via the mitochondrial-stem cell connection
•
Phase II clinical trial active — IVM + pembrolizumab (anti-PD1) in metastatic TNBC (NCT05318469)
Published 75% Response Rate: Dr. Makis reports a 75% response rate across all cancer types with IVM + Mebendazole combination therapy across 480+ documented case reports.
🇺🇸 FLORIDA: $60 MILLION State Investment in Ivermectin Cancer Research
On
World Cancer Research Day (September 24, 2025), Governor Ron DeSantis and First Lady Casey DeSantis — herself a breast cancer survivor — announced the largest state investment ever in repurposed drug cancer research through the
Florida Cancer Innovation Fund (Casey DeSantis Cancer Research Program, §381.915 FL Statutes).
"Generic medicines are often overlooked because they're off-patent and don't necessarily promise big profits. Florida is investing in researching them to learn more and hopefully uncover new ways to beat cancer."
— Casey DeSantis, First Lady of Florida
"We're uniquely positioned to do this because Big Pharma doesn't profit from relatively cheap drugs like ivermectin."
— Dr. Joseph Ladapo, Florida Surgeon General
Key Details:
•
$60 million Year 3 funding — previous years funded 95 researchers with $80M
• Official priority:
"the repurposing of generic drugs such as ivermectin for cancer treatment"
• Funds 12-month clinical trials, translational research, nutrition-based strategies
• Casey DeSantis directly cited Mel Gibson's Joe Rogan appearance as a catalyst
• Dr. Paul Marik (FLCCC, co-author of the IVM+MBZ protocol used in this guide) highlighted IVM's effectiveness in combination with other drugs at the announcement
• Announced at University of South Florida Morsani College of Medicine
Source: Florida Governor's Office & Florida Department of Health (Sept 24, 2025)
🔬 Ivermectin Synergy with Every Protocol Compound
IVM reverses P-glycoprotein multidrug resistance (PMID 33493461), meaning it enhances absorption and cancer-cell retention of every compound below:
IVM + Curcumin: Both inhibit NF-κB and Wnt/β-catenin pathways from different angles — IVM via PAK1 kinase, curcumin via IκBα stabilization. The 2024 Baghli/Makis/Marik protocol specifically pairs IVM with bioavailable curcumin (600mg/day) as a core synergistic combination. IVM's P-gp inhibition increases curcumin bioavailability.
[PMID 32971268] [PMID 31025419]
IVM + Berberine: Both target AMPK activation and mTOR inhibition. Berberine blocks glucose uptake (mimicking metabolic starvation), while IVM inhibits Akt/mTOR. The Makis protocol specifically includes berberine (500mg/day) alongside IVM to "starve your cancer of sugar." Both drugs independently suppress cancer stem cell renewal.
[PMID 30224620] [PMID 34466270]
IVM + Vitamin D3: The Makis protocol includes Vitamin D3 (up to 50,000 IU/day adjusted by blood level) alongside IVM. IVM enhances anti-PD-1 checkpoint immunotherapy
[PMID 36253547], while D3 modulates PD-L1 expression and enhances dendritic cell function
[PMID 31575510] — dual immune activation via the same checkpoint axis.
IVM + Resveratrol: IVM suppresses Wnt/β-catenin
[PMID 32971268] while resveratrol activates SIRT1/AMPK and p53 pathways
[PMID 21575098]. Both converge on PI3K/AKT suppression — attacking the same survival pathway from upstream and downstream entry points.
IVM + Quercetin: IVM reverses P-gp efflux resistance
[PMID 33493461], increasing intracellular retention of quercetin in cancer cells. Quercetin inhibits DNA repair mechanisms
[PMID 36444390], while IVM induces DNA damage via oxidative stress — making cells take damage they can't repair.
IVM + Black Seed Oil (Thymoquinone): Both independently suppress NF-κB — IVM via PAK1 kinase inhibition
[PMID 32971268], thymoquinone via IκBα stabilization
[PMID 25685735]. NF-κB is the master switch cancer uses for survival, inflammation, and metastasis — dual-blockade means higher kill probability.
IVM + Turkey Tail (PSK/PSP): IVM converts cold tumors hot and induces immunogenic cell death
[PMID 33649334]. Turkey tail PSK activates the dendritic cells and NK cells that respond to ICD signals
[PMID 22972297]. IVM exposes the cancer to the immune system; turkey tail arms the immune system to destroy it.
IVM + EGCG: IVM inhibits EGFR through Akt/mTOR suppression
[PMID 34466270]. EGCG independently inhibits EGFR and NF-κB
[PMID 19838169]. Multi-site EGFR blockade from two independent compounds prevents compensatory pathway escape.
IVM + Tocotrienols: Both target cancer stem cells. IVM inhibits CSC self-renewal via PAK1/Akt
[PMID 32474842]. Delta-tocotrienol suppresses CSC-maintaining NF-κB and Wnt signaling
[PMID 24269738]. Combination targets the stem-cell reservoir that drives relapse.
IVM + Milk Thistle (Silymarin): Silymarin provides hepatoprotection during IVM therapy
[PMID 28861042]. Silymarin also independently inhibits cancer proliferation via STAT3 suppression — adding anti-cancer activity while protecting the liver from drug metabolism demands.
IVM + Probiotics: The gut microbiome directly predicts immunotherapy response
[PMID 25568218]. IVM's oral bioavailability depends on healthy gut absorption. Probiotics maintain the gut barrier integrity that enables consistent IVM and supplement absorption, while supporting the immune system IVM activates.
IVM + Lactoferrin: IVM activates immunogenic cell death and T-cell infiltration
[PMID 33649334]. Lactoferrin activates NK cells and macrophages
[PMID 24440737]. Together they create a two-pronged immune activation: IVM recruits the cells, lactoferrin arms them.
IVM + Chlorella: Chlorella stimulates NK cell activity and interferon-gamma
[PMID 22849818], enhancing the anti-tumor immune response that IVM's immunogenic cell death initiates
[PMID 33649334]. Chlorella also binds heavy metals and toxins released during cancer cell die-off.
IVM + Zinc: Zinc deficiency impairs p53 tumor suppressor function
[PMID 31164639]. IVM induces apoptosis via p53-dependent pathways in many cancer types. Zinc ensures p53 is functional so IVM's apoptosis signals are executed. Zinc also restores thymic T-cell production
[PMID 28961870] depleted by cancer.
IVM + Fasting: Fasting activates AMPK, depletes glucose, and reduces IGF-1. IVM inhibits Akt/mTOR
[PMID 34466270]. Together they create a metabolic pincer: fasting cuts the fuel supply while IVM blocks the survival pathway cancer cells use when starved. Normal cells enter protective autophagy
[PMID 29086496]; cancer cells cannot.
🔬 Mebendazole Synergy with Every Protocol Compound
MBZ disrupts tubulin/microtubules and inhibits VEGFR2 angiogenesis (PMID 31489501), creating synergies with every compound that targets different pathways:
MBZ + Curcumin: MBZ disrupts microtubules arresting cells in G2/M
[PMID 33254747]; curcumin inhibits NF-κB survival signals cancer cells use to escape apoptosis after mitotic arrest
[PMID 31025419]. The combination blocks both the structural division AND the survival signaling simultaneously. The Makis protocol specifically pairs MBZ with curcumin.
MBZ + Berberine: Berberine inhibits glycolysis and activates AMPK
[PMID 30224620]. MBZ disrupts glucose uptake via microtubule disruption (the same mechanism used against parasites). Dual glucose starvation from two independent mechanisms collapses cancer cell energy metabolism.
MBZ + Vitamin D3: MBZ + radiation synergy is enhanced in G2/M arrested cells
[PMID 30196056]. D3 modulates DNA damage repair pathways
[PMID 32235024]. MBZ arrests cells while D3 impairs their repair — cells break and can't fix themselves. D3 also enhances immune surveillance that cleans up MBZ-damaged cells.
MBZ + Resveratrol: MBZ causes mitotic catastrophe and double-strand DNA breaks
[PMID 30196056]. Resveratrol activates p53 and SIRT1-mediated apoptosis
[PMID 21575098]. MBZ breaks the microtubules; resveratrol ensures the resulting DNA damage triggers cell death rather than repair.
MBZ + Quercetin: MBZ arrests cells in G2/M phase
[PMID 33254747]. Quercetin inhibits DNA repair mechanisms and induces mitochondrial apoptosis
[PMID 36444390]. Cancer cells arrested by MBZ with compromised DNA repair from quercetin cannot divide and cannot recover — forced cell death.
MBZ + Black Seed Oil (Thymoquinone): Both independently inhibit angiogenesis — MBZ via VEGFR2 inhibition
[PMID 31489501], thymoquinone via suppression of VEGF expression
[PMID 25685735]. Dual anti-angiogenic attack cuts blood supply to the tumor from two independent mechanisms.
MBZ + Turkey Tail (PSK/PSP): MBZ polarizes macrophages from immunosuppressive M2 to anti-tumor M1 phenotype
[PMID 31489501]. Turkey tail PSK activates dendritic cells and enhances NK cell cytotoxicity
[PMID 22972297]. MBZ reprograms the immune environment; turkey tail charges the immune cells to attack.
MBZ + EGCG: MBZ inhibits BRAF kinase in melanoma and colorectal cancer
[PMID 31489501]. EGCG inhibits EGFR and NF-κB
[PMID 19838169]. Dual kinase inhibition from two safe, off-patent agents — MBZ hits BRAF/TNIK, EGCG hits EGFR — covering multiple oncogenic driver mutations.
MBZ + Tocotrienols: MBZ synergizes with docetaxel by augmenting microtubule disruption and G2/M arrest
[PMID 31681931]. Tocotrienols sensitize cancer cells to apoptosis via NF-κB suppression
[PMID 24269738]. MBZ creates the structural damage; tocotrienols remove the survival safety net.
MBZ + Milk Thistle (Silymarin): MBZ is hepatically metabolized and can elevate liver enzymes at sustained doses. Silymarin protects hepatocytes from drug-induced oxidative stress
[PMID 28861042]. This is why milk thistle is
non-negotiable in this protocol — it is the safety mechanism that enables sustained MBZ dosing.
MBZ + Probiotics: Probiotics maintain gut barrier integrity and reduce drug-induced GI toxicity
[PMID 28292750]. MBZ is absorbed orally and can cause GI discomfort at high doses. Probiotics also enhance overall immune function
[PMID 31479461], supporting the anti-tumor immune response MBZ's M1 macrophage polarization initiates.
MBZ + Lactoferrin: MBZ activates anti-tumor M1 macrophages
[PMID 31489501]. Lactoferrin further activates NK cells and modulates inflammatory cytokines
[PMID 24440737]. Together: MBZ reprograms the tumor immune microenvironment + lactoferrin supercharges the innate immune effectors.
MBZ + Chlorella: Chlorella activates macrophages and dendritic cells via TLR pathway
[PMID 20013177]. MBZ polarizes macrophages to M1 anti-tumor phenotype
[PMID 31489501]. MBZ directs the immune cells to fight cancer; chlorella activates and expands that immune army.
MBZ + Zinc: MBZ causes DNA double-strand breaks
[PMID 30196056]. Zinc deficiency impairs p53 tumor suppressor
[PMID 31164639]. Adequate zinc ensures p53 can detect MBZ-induced DNA damage and trigger apoptosis. Zinc also supports immune cell production to clear MBZ-damaged cancer cells.
MBZ + Fasting: Cancer cells under metabolic stress from fasting (glucose deprivation, reduced IGF-1) are significantly more vulnerable to MBZ's microtubule disruption. Healthy cells in a fasting state enter differential stress resistance
[PMID 29086496] — making them MORE resistant to MBZ while cancer cells become MORE vulnerable. A ketogenic diet with MBZ enhanced efficacy in pediatric glioma preclinical models.
📚 Drug Synergy & Combination Research:
📄
PubMed 32971268 — IVM: comprehensive review of anti-cancer mechanisms via multiple signaling pathways
📄
PubMed 32474842 — IVM synergistic with docetaxel, cyclophosphamide, tamoxifen in breast cancer
📄
PubMed 35822934 — IVM + gemcitabine: synergistic apoptosis via mitochondrial dysfunction in pancreatic cancer
📄
PubMed 33649334 — IVM converts cold tumors hot, synergizes with anti-PD1 in breast cancer (p<0.001)
📄
PubMed 33493461 — IVM reverses P-glycoprotein multidrug resistance in cancer cells
📄
PubMed 33523115 — IVM + doxorubicin synergistic lethality overcomes drug resistance
📄
PubMed 36253547 — IVM enhances anti-PD-1 immunotherapy response via Treg suppression
📄
PubMed 34560032 — IVM + cisplatin: Akt/mTOR pathway synergy in ovarian cancer
📄
PubMed 34220783 — Antiparasitic drugs repurposed for cancer: shared targets with anti-tumor drugs
📄
PubMed 31489501 — MBZ comprehensive oncology review: tubulin, angiogenesis, kinase, immune mechanisms
📄
PubMed 33254747 — MBZ disrupts tubulin polymerization, G2/M arrest, apoptosis in cancer
📄
PubMed 30196056 — MBZ potent radiosensitizer: depletes cancer stem cells, DNA double-strand breaks in TNBC
📄
PubMed 36555137 — MBZ + radiation increases NK cell-mediated cytotoxicity in TNBC
📄
PubMed 31681931 — MBZ synergizes with docetaxel in prostate cancer treatment
📄
PubMed 28852916 — MBZ + temozolomide potentiates efficacy in glioblastoma
📄
PubMed 33506200 — Phase 1 clinical trial: MBZ + TMZ in high-grade glioma, 21-month survival
📄
PubMed 35747192 — Phase 2 trial: MBZ + TMZ and MBZ + lomustine in recurrent GBM
📄
PubMed 24269738 — Tocotrienols synergize with gemcitabine in pancreatic cancer
📄
PubMed 25685735 — Thymoquinone synergizes with conventional chemotherapy agents
📄
PubMed 28861042 — Silymarin enhances cisplatin anti-cancer activity, hepatoprotective
📄
PubMed 30224620 — Berberine enhances doxorubicin anti-cancer activity via AMPK/NF-κB
📄
PubMed 21575098 — Resveratrol synergizes with doxorubicin in breast cancer
🥗 Section 7: Anti-Cancer Diet Protocol
"Do you not know that your bodies are temples of the Holy Spirit, who is in you, whom you have received from God? You are not your own."
— 1 Corinthians 6:19 (NIV)
🟢 EAT DAILY: Cruciferous vegetables (sulforaphane = same Nrf2 pathway as curcumin), Berries (quercetin + resveratrol analogs), Wild fatty fish (omega-3s reduce NF-kB), Garlic & onions (allicin + quercetin), Green tea (extra EGCG), Turmeric with pepper, Fermented foods (reinforce probiotics), Dark leafy greens (chlorophyll = chlorella support), Mushrooms (beta-glucans = turkey tail), Nuts & seeds
🔴 ELIMINATE: All refined sugar, Processed meats, Seed oils (canola/soybean/corn/sunflower), Alcohol, Ultra-processed foods, Deep-fried foods, White flour/refined grains
📚 Anti-Cancer Nutrition Research:
📄
PubMed 27615408 — Mediterranean diet reduces cancer mortality — large cohort study
📄
PubMed 29735388 — Sugar and cancer: high glycemic diet accelerates tumor growth
📄
PubMed 29570100 — Processed meat classified as Group 1 carcinogen by WHO/IARC
📄
PubMed 29893775 — Ketogenic diet enhances anti-cancer therapy — clinical review
📄
PubMed 29514064 — Cruciferous vegetables: sulforaphane inhibits cancer via Nrf2 pathway
📄
PubMed 32341551 — Organic food consumption linked to lower cancer risk — JAMA study
📄
PubMed 30048243 — Omega-3 fatty acids suppress tumor inflammation and angiogenesis
📄
PubMed 31462907 — Fiber intake inversely associated with colorectal cancer risk
📄
PubMed 28611066 — Anti-inflammatory diet reduces cancer incidence — longitudinal study
📄
PubMed 33076928 — Dairy hormones and IGF-1: potential cancer-promoting effects
🍽️ 7-Day Anti-Cancer Meal Plan
This meal plan integrates the protocol's dietary principles: low glycemic, high antioxidant, anti-inflammatory, autophagy-supportive. Every meal deliberately includes foods that reinforce the 17 compounds. All meals fit within the 16:8 fasting window (eating window: 12pm–8pm).
📅 Day 1 — Monday
12:00 PM — Break-Fast Meal: Wild-caught salmon bowl with steamed broccoli, sauerkraut, raw red onion (quercetin), avocado, pumpkin seeds (zinc), drizzle of extra virgin olive oil, turmeric-black pepper dressing.
3:00 PM — Snack: Green tea (EGCG) + handful of raw walnuts + 3 Brazil nuts (selenium).
7:00 PM — Dinner: Grass-fed beef stir-fry with shiitake mushrooms, garlic, ginger, bok choy, cauliflower rice. Side of kimchi. Dessert: mixed berries (blueberries, raspberries) with a drizzle of raw honey.
📅 Day 2 — Tuesday
12:00 PM — Break-Fast Meal: Organic eggs (3) scrambled with turmeric + black pepper, sautéed kale, diced tomatoes, sliced avocado. Side of natto (vitamin K2).
3:00 PM — Snack: Matcha latte (unsweetened) + apple slices with almond butter.
7:00 PM — Dinner: Baked wild cod with lemon-garlic sauce, roasted Brussels sprouts (sulforaphane), sweet potato (moderate portion), side of raw sauerkraut. Dessert: dark chocolate (85%+ cacao, 2 squares).
📅 Day 3 — Wednesday
12:00 PM — Break-Fast Meal: Bone broth soup with shredded organic chicken, turmeric, ginger, celery, carrots, and fresh parsley. Side of mixed greens salad with capers (quercetin), radish, olive oil + apple cider vinegar dressing.
3:00 PM — Snack: Green tea + organic celery with black seed oil drizzle + raw pumpkin seeds.
7:00 PM — Dinner: Grass-fed lamb chops with rosemary, roasted cauliflower and broccoli (cruciferous), sautéed spinach with garlic. Side of fermented pickles. Dessert: frozen mixed berries.
📅 Day 4 — Thursday
12:00 PM — Break-Fast Meal: Sardines on sprouted grain toast with avocado, red onion (quercetin), lemon juice, fresh dill. Side salad with arugula, walnuts, olive oil.
3:00 PM — Snack: Turmeric golden milk (coconut milk + turmeric + black pepper + cinnamon) + handful of almonds.
7:00 PM — Dinner: Turkey meatballs (organic) with marinara sauce (lycopene), spaghetti squash, steamed broccoli. Side of miso soup with seaweed. Dessert: sliced strawberries with coconut cream.
📅 Day 5 — Friday
12:00 PM — Break-Fast Meal: Wild-caught shrimp and vegetable curry (coconut milk, turmeric, ginger, garlic, bell peppers, spinach) over cauliflower rice. Side of raw sauerkraut.
3:00 PM — Snack: Green tea + grass-fed cheese (K2) + raw walnuts + celery sticks.
7:00 PM — Dinner: Grilled organic chicken thighs with chimichurri (parsley, garlic, olive oil), roasted root vegetables (beets, carrots, turnips), side of mixed greens with red onion. Dessert: baked apple with cinnamon and walnuts.
📅 Day 6 — Saturday
12:00 PM — Break-Fast Meal: Smoked wild salmon + organic eggs (poached), sautéed mushrooms (shiitake, maitake — beta-glucans), wilted spinach, cherry tomatoes, sliced avocado.
3:00 PM — Snack: Matcha + organic berries smoothie (blueberries, raspberries, coconut milk, 1 tbsp ground flaxseed).
7:00 PM — Dinner: Grass-fed bison burgers (lettuce wrap), topped with sauerkraut, red onion, mustard. Side of sweet potato fries (baked), coleslaw with apple cider vinegar. Dessert: dark chocolate (85%+) with Brazil nuts.
📅 Day 7 — Sunday (Optional 24hr Fast Day or Eat Light)
Option A — 24-Hour Fast: Water, black coffee, green tea, and bone broth only. This extended fast maximizes autophagy and immune cell regeneration. Break fast Monday at noon.
Option B — Light Eating Day:
12:00 PM: Large bowl of vegetable soup (broccoli, cauliflower, kale, garlic, turmeric, ginger, bone broth base). Side of fermented vegetables.
6:00 PM: Wild-caught fish (salmon or mackerel) with steamed vegetables, small salad with olive oil + lemon. No dessert — let the body rest.
🔑 Meal Plan Key Principles
✅ Every meal includes at least 2 protocol-reinforcing foods (quercetin-rich onions, zinc-rich pumpkin seeds, K2-rich natto/cheese, beta-glucan mushrooms, sulforaphane-rich cruciferous vegetables, anti-inflammatory turmeric).
✅ All meals fit within 16:8 fasting window (12pm-8pm eating, 8pm-12pm fasting).
✅ Sunday optional 24-hour fast aligns with weekly autophagy protocol.
✅ Zero refined sugar, zero processed food, zero conventional dairy, zero seed oils.
✅ Every protein source is wild-caught, grass-fed, or organic pastured.
✅ Green tea consumed daily for EGCG synergy with supplements.
✅ Fermented foods at every dinner for probiotic/microbiome support.
🏥 Section 11: Treatment Options & Clinic Directory
Helping Cancer Fighters Make the Best Informed Decision
Every cancer journey is unique. Some people choose a fully natural approach. Others combine natural compounds with conventional treatment. Some pursue cutting-edge therapies like CAR-T cell therapy or EBOO ozone therapy. There is no single right answer — only the right answer for you.
This section exists so that if you choose to pursue chemotherapy, radiation, immunotherapy, or advanced treatments, you have the published research showing how the compounds in this protocol can work alongside those treatments. The goal is simple: give you every advantage possible, no matter which path you choose.
Always coordinate supplement use with your oncology team, especially around infusion and radiation schedules. Bring this research to them — an informed patient is an empowered patient.
"For You formed my inward parts; You covered me in my mother's womb. I will praise You, for I am fearfully and wonderfully made."
— Psalm 139:13-14 (NKJV)
🛡️ Your Immune System Was Designed to Defeat Cancer — Here's the Proof
Your body produces between 10,000 to 100,000 abnormal cells every single day. And every single day, a fully functioning immune system identifies and destroys them before they ever become tumors. This is not theory — it is
immunosurveillance, one of the most well-documented phenomena in cancer biology.
The Published Evidence:
•
Spontaneous tumor regression — documented cases of advanced cancers (including melanoma, hepatocellular carcinoma, and renal cell carcinoma) completely disappearing without treatment, driven by sudden immune activation
[PMID 22870091]
•
Immunosuppressed patients get 3–100x more cancers — organ transplant recipients on immunosuppressive drugs develop cancers at dramatically higher rates, proving the immune system actively holds cancer in check
[JCI 2007]
•
CD8+ T cells destroy tumors — in spontaneously regressing melanomas, researchers found clonal expansion of cytotoxic T cells directly targeting and eliminating cancer cells
[PMID 12845635]
•
NK cells are your frontline — Natural Killer cells are innate tumor surveillance agents. They need no prior sensitization and preferentially destroy malignant cells. People with low NK cell activity have significantly higher cancer incidence
[PMC 2017]
•
Mice without immune function get 60%+ more spontaneous tumors — mice deficient in IFN-γ or lymphocytes develop dramatically more cancers, confirming immune surveillance is essential
[Frontiers 2025]
•
Complete liver cancer regression from immune activation alone — a 65-year-old woman with a 17cm infiltrative hepatocellular carcinoma experienced complete spontaneous regression. Immunophenotyping revealed massive expansion of cytotoxic CD8+ T cells and inflammatory monocytes
[PMC 2021]
What This Means for You:
Cancer is not a death sentence — it is an immune system failure. When your immune system is restored to full capacity through proper nutrition, targeted supplementation, exercise, fasting, sleep, reduced inflammation, and elimination of toxins — it has the documented ability to identify, attack, and destroy cancer cells on its own.
Every single compound in this protocol was selected because it supports one or more of these immune mechanisms.
"But He was wounded for our transgressions, He was bruised for our iniquities; the chastisement for our peace was upon Him, and by His stripes we are healed."
— Isaiah 53:5 (NKJV)
⚡ AUTHORITATIVE AGENTS — The Force Multipliers
These two repurposed drugs have the deepest published evidence for enhancing conventional cancer treatment. Both are inexpensive, well-tolerated, and backed by human clinical trial data.
💊 Ivermectin — Enhancing Conventional Treatment
💉 With Chemotherapy:
IVM reverses P-glycoprotein multidrug resistance — the primary pump cancer cells use to eject chemotherapy drugs
[PMID 33493461]. IVM synergizes with doxorubicin in breast cancer, overcoming drug resistance
[PMID 33523115]; with gemcitabine in pancreatic cancer via synergistic apoptosis
[PMID 35822934]; with cisplatin in ovarian cancer by inhibiting the Akt/mTOR survival pathway
[PMID 34560032]; and with docetaxel/cyclophosphamide in multiple cancer types at clinically feasible concentrations
[PMID 32474842]. IVM also augments chemotherapy efficacy in osteosarcoma, acting synergistically with doxorubicin in both in vitro and mouse models
[PMID 36503300].
☢️ With Radiation:
Antiparasitic anthelmintics (the drug class including IVM and MBZ) sensitize cancer cells to ionizing radiation via synergistic G2/M cell cycle arrest
[PMID 22094106]. IVM downregulates HSPB1 phosphorylation — a cancer-protective stress response that tumors use to survive radiation damage.
🛡️ With Immunotherapy:
IVM enhances anti-PD-1 checkpoint immunotherapy response. It reduces immunosuppressive regulatory T-cells (Tregs) in the tumor microenvironment — the same cells that prevent checkpoint inhibitors from working. By clearing the immunosuppressive shield, IVM allows checkpoint inhibitors to activate the full anti-tumor immune response
[PMID 36253547].
💊 Mebendazole — Enhancing Conventional Treatment
💉 With Chemotherapy:
MBZ uses the same microtubule-disrupting mechanism as vincristine and paclitaxel but with a dramatically superior safety profile
[PMID 31489501]. MBZ induces apoptosis in chemoresistant melanoma cells where conventional agents fail, via caspase-3/7 pathway activation
[PMID 30405127]. MBZ combined with temozolomide potentiates efficacy in TMZ-resistant glioblastoma cell lines
[PMID 28852916]. A
Phase 1 clinical trial of MBZ + temozolomide in 24 newly diagnosed high-grade glioma patients demonstrated safety at doses up to 200 mg/kg with encouraging 21-month median survival
[PMID 33506200]. A
Phase 2 randomized trial further evaluated MBZ + TMZ and MBZ + lomustine in recurrent GBM
[PMID 35747192].
☢️ With Radiation:
MBZ is a potent radiosensitizer. It arrests cancer cells in the G2/M phase — the phase most sensitive to radiation damage. In triple-negative breast cancer (TNBC), MBZ potentiated radiation at all doses tested, depleted radiation-resistant cancer stem cells, and caused DNA double-strand breaks and apoptosis
[PMID 30196056]. In radiation-resistant TNBC, MBZ + RT increased NK cell-mediated cytotoxicity — meaning MBZ helps the immune system clean up what radiation damages
[PMID 36555137]. In meningioma, MBZ + radiation increased survival through combined apoptosis induction, proliferation reduction, and angiogenesis inhibition
[PMID 29422509] [PMID 30414098].
🌿 PROTOCOL SUPPLEMENTS — Conventional Treatment Synergies
Every supplement in this protocol has published evidence showing it can enhance chemotherapy, radiation, and/or immunotherapy outcomes. Here is what the research shows for each one.
🟡 Curcumin (Turmeric Extract)
💉 With Chemotherapy:
Curcumin sensitizes tumors to doxorubicin, 5-FU, paclitaxel, vincristine, cisplatin, gemcitabine, oxaliplatin, and etoposide
[PMID 35216255]. It reverses cisplatin resistance in lung cancer by inhibiting the FA/BRCA DNA repair pathway
[PMID 25542235]. Curcumin-cisplatin co-delivery improves efficacy while reducing side effects
[PMID 34347326].
☢️ With Radiation:
Curcumin is both a radiosensitizer for tumors AND a radioprotector for normal tissue — a remarkable dual role
[PMID 20924967]. A
randomized clinical trial confirmed curcumin is an effective radiosensitizer in cervical cancer treatment
[PMID 33507691]. The curcumin + cisplatin + radiation triple combination achieved a sensitization enhancement ratio of 1.96x in NSCLC
[PMID 31289524].
🛡️ Tissue Protection:
While sensitizing tumors, curcumin simultaneously
protects normal organs — liver, kidneys, oral mucosa, and heart — from chemo/radiation toxicity via NRF2 activation and antioxidant enzyme induction
[PMID 20924967].
🟡 Resveratrol
💉 With Chemotherapy:
Resveratrol synergizes with doxorubicin in breast cancer
[PMID 21575098]. It enhances cisplatin cytotoxicity in ovarian cancer cells by suppressing PI3K/AKT and activating p38 MAPK
[PMID 37242538]. Resveratrol also prevents the development of cisplatin resistance when co-administered over treatment cycles
[PMID 26918049].
☢️ With Radiation:
Resveratrol inhibits STAT3 signaling, a key survival pathway cancer cells activate after radiation exposure. This prevents radiation-induced cancer cell recovery.
🟡 Black Seed Oil (Thymoquinone)
💉 With Chemotherapy:
Thymoquinone synergizes with conventional chemotherapy agents across multiple cancer types, enhancing cytotoxicity while reducing side effects
[PMID 25685735].
☢️ With Radiation:
Thymoquinone sensitizes cancer cells to radiation therapy through multiple mechanisms including ROS generation and DNA repair inhibition
[PMID 30116777].
🟡 Berberine
💉 With Chemotherapy:
Berberine enhances doxorubicin anti-cancer activity through AMPK activation and NF-kB suppression
[PMID 30224620].
🛡️ With Immunotherapy:
Berberine reduces myeloid-derived suppressor cells (MDSCs) and regulatory T-cells — both key immunosuppressive cell populations that limit checkpoint inhibitor efficacy. AMPK activation by berberine also remodels the tumor microenvironment to favor immune infiltration.
🟡 Quercetin
💉 With Chemotherapy:
Quercetin inhibits DNA repair mechanisms in cancer cells, making them more vulnerable to DNA-damaging chemo agents. Acts as both chemopreventive and chemotherapeutic agent, enhancing sensitivity to cisplatin and 5-FU
[PMID 36444390].
🟡 Milk Thistle (Silymarin)
💉 With Chemotherapy:
Silibinin enhances cisplatin anti-cancer activity
[PMID 28861042].
🛡️ Tissue Protection:
Protects the liver during chemotherapy — a critical dual role since liver toxicity is the #1 dose-limiting factor for many chemo regimens. Systematic review confirms hepatoprotective effects without reducing chemo efficacy
[PMID 32345678].
🟡 Tocotrienols (Vitamin E)
💉 With Chemotherapy:
Delta-tocotrienol synergizes with gemcitabine in pancreatic cancer. Tocotrienols broadly sensitize cancer cells to multiple chemotherapy agents
[PMID 24269738].
🟡 EGCG (Green Tea Extract)
☢️ With Radiation:
EGCG enhances radiation-induced apoptosis in cancer cells while protecting normal tissue from radiation oxidative damage
[PMID 26773455]. EGCG also sensitizes cancer cells to cisplatin and other chemotherapeutic agents by inhibiting NF-κB and EGFR signaling
[PMID 19838169].
🟡 Vitamin D3
☢️ With Radiation:
Optimal D3 levels improve radiation response. D3 modulates DNA damage repair pathways in cancer cells, making them more susceptible to radiation-induced killing
[PMID 32235024].
🛡️ With Immunotherapy:
D3 modulates PD-L1 expression — the very ligand that checkpoint inhibitors target. Optimal D3 levels support the immune system's ability to mount an anti-tumor response. D3 also enhances dendritic cell function and T-cell differentiation
[PMID 31575510].
🟡 Turkey Tail Mushroom
🛡️ With Immunotherapy:
Turkey tail PSK/PSP activate dendritic cells — the same antigen-presenting cells that checkpoint inhibitors like pembrolizumab (Keytruda) and nivolumab (Opdivo) rely on. PSK is an approved anti-cancer adjuvant in Japan, used alongside conventional therapy for decades. Turkey tail beta-glucans prime the immune system to recognize and attack tumor cells
[PMID 22972297].
🟡 Probiotics & Gut Microbiome
🛡️ With Immunotherapy:
The gut microbiome directly predicts immunotherapy response. Patients with diverse gut microbiomes respond significantly better to anti-PD-1 therapy
[PMID 25568218]. Microbiome composition is now considered a biomarker for immunotherapy success
[PMID 31479461].
🛡️ Tissue Protection:
Probiotics reduce chemotherapy-induced diarrhea, mucositis, and gut dysbiosis
[PMID 28292750]. They maintain the gut barrier that chemo damages.
🟡 Chlorella
🛡️ With Immunotherapy:
Chlorella stimulates NK cell activity and promotes interferon-gamma production, supporting the cytotoxic immune response that immunotherapy depends on
[PMID 22849818]. Chlorella polysaccharides activate macrophages and dendritic cells via TLR pathway signaling
[PMID 20013177].
🟡 Lactoferrin
🛡️ With Immunotherapy:
Lactoferrin promotes NK cell and macrophage activation while modulating inflammatory cytokines — supporting the immune cascade that checkpoint inhibitors initiate
[PMID 24440737]. Bovine lactoferrin demonstrates direct anti-tumor activity by inducing apoptosis and inhibiting angiogenesis in multiple cancer models
[PMID 25015735].
🔄 LIFESTYLE STRATEGIES — Amplifying Conventional Treatment
🟡 Fasting (48–72h Around Infusions)
💉 With Chemotherapy:
Short-term fasting (48–72h surrounding chemo infusions) protects normal cells from chemo toxicity while making cancer cells MORE vulnerable — a phenomenon called "differential stress resistance"
[PMID 29086496]. Fasting cycles retard tumor growth and sensitize multiple cancer types to chemotherapy
[PMID 25462853]. Cancer cells cannot enter protective mode during nutrient deprivation; healthy cells can.
🛡️ Tissue Protection:
Normal cells enter a protected state during fasting — cancer cells cannot. This is one of the most powerful and free strategies to protect your body during treatment.
🟡 Zinc
🛡️ Tissue Protection:
Enhances response to chemotherapy while supporting immune recovery between cycles. Zinc deficiency — common in cancer patients — impairs p53 tumor suppressor function
[PMID 31164639]. Zinc supplementation restores thymic function and T-cell counts depleted by chemotherapy
[PMID 28961870].
🔬 HOW IVM & MBZ ACTUALLY KILL CANCER — 9 PROVEN MECHANISMS
These are not anti-parasitic drugs repurposed on a hunch. Peer-reviewed research has identified at least 9 distinct, scientifically validated mechanisms by which Ivermectin and Mebendazole independently attack cancer — none of which depend on the drugs' original anti-parasitic function.
🧬 IVERMECTIN — 6 Anti-Cancer Mechanisms
1. Shuts Down Cancer's Master Growth Switch (Akt/mTOR Pathway)
Cancer cells hijack the Akt/mTOR signaling pathway to fuel unlimited growth. IVM degrades PAK1 kinase via ubiquitination, which collapses Akt phosphorylation and shuts down mTOR — the master regulator of cancer cell proliferation. This induces cytostatic autophagy: the cancer cell literally digests itself. Demonstrated in breast cancer, ovarian cancer, glioblastoma, and NF2 tumors both in vitro and in vivo
[PMID 27302166] [PMID 32971268].
2. Blocks Cancer's Self-Renewal Program (WNT/β-Catenin Pathway)
The WNT pathway drives cancer stem cell self-renewal and tumor recurrence. IVM suppresses WNT-TCF transcriptional activity, represses β-catenin phosphorylation, and downregulates cyclin D1 — a key oncogene driving the cell cycle. In colon cancer xenografts, IVM eliminated up to 73% of floating spheroids (cancer stem cell colonies) without discernible side effects
[PMID 25646014]. Also inhibits lung and breast cancer via the same pathway
[PMID 32971268].
3. Destroys Cancer Cell Mitochondria (Energy Starvation)
Cancer cells are energy-hungry — they need massive ATP production to sustain rapid division. IVM inhibits mitochondrial Complex I, collapsing the electron transport chain. This drops the mitochondrial membrane potential, slashes ATP production, and floods the cell with reactive oxygen species (ROS) and mitochondrial superoxide. The cancer cell cannot produce enough energy to survive. Demonstrated dose-dependently in glioblastoma, renal cell carcinoma, and chronic myeloid leukemia cells — while sparing normal cells
[PMID 27771251] [PMID 28818736].
4. Reverses Drug Resistance (P-Glycoprotein Inhibition)
Over 90% of chemotherapy deaths are linked to drug resistance. Cancer cells express P-glycoprotein (P-gp) efflux pumps that physically eject chemotherapy drugs before they can work. IVM inhibits P-gp, trapping drugs inside cancer cells. In the first study of IVM's anti-cancer potential (1996), IVM-treated leukemia cells became
60-fold more sensitive to vinblastine and doxorubicin. This P-gp inhibition also means IVM increases the effectiveness of MBZ and every other compound in this protocol
[PMID 33493461].
5. Turns "Cold" Tumors "Hot" (Immunogenic Cell Death)
Many tumors evade the immune system by suppressing T-cell infiltration — so-called "cold" tumors that immunotherapy cannot reach. IVM induces immunogenic cell death (ICD): cancer cells release danger signals (ATP, calreticulin, HMGB1) that recruit immune cells to attack. In breast cancer models, IVM combined with anti-PD1 immunotherapy achieved
synergistic complete tumor regression (p<0.001) — converting immunologically invisible tumors into targets the immune system destroyed
[PMID 33649334].
6. Floods Cancer Cells with Chloride Ions (Membrane Disruption)
IVM acts as an ionophore — it opens chloride channels in cancer cell membranes, causing massive chloride influx. This hyperpolarizes the membrane, disrupts cellular volume regulation, generates oxidative damage via ROS, and pushes cancer cells toward apoptosis. Cancer cells are more vulnerable to this than normal cells because they depend more heavily on chloride channel regulation for survival and rapid growth
[PMID 20644115].
🧬 MEBENDAZOLE — 5 Anti-Cancer Mechanisms
1. Destroys Cancer Cell Skeleton (Microtubule Disruption)
Cancer cells divide rapidly and depend on microtubules — the structural scaffolding that pulls chromosomes apart during cell division. MBZ binds to the colchicine site on β-tubulin and prevents microtubule polymerization. Cancer cells arrested in metaphase cannot complete division, triggering intrinsic apoptosis via mitochondrial membrane permeabilization and cytochrome c release. This is the same mechanism as the chemotherapy drugs vincristine and paclitaxel, but MBZ has a dramatically safer side-effect profile. Effective at nanomolar concentrations in lung, colon, breast, brain, and melanoma cancer cell lines
[PMID 33254747] [PMID 31489501].
2. Starves Tumors of Blood Supply (VEGFR2 Angiogenesis Inhibition)
Tumors require new blood vessel formation (angiogenesis) to grow beyond a few millimeters. MBZ directly binds and inhibits VEGFR2 kinase — the master switch for tumor angiogenesis — by competing with ATP at the active site (IC50 = 3.6 µM). In brain tumor models, MBZ significantly reduced tumor blood vessel density while leaving normal brain vasculature completely unaffected. In lung cancer xenografts, MBZ inhibited formation of metastatic colonies by approximately 80%
[PMID 25253417] [PMID 31489501].
3. Blocks Multiple Cancer Driver Mutations (Multi-Kinase Inhibition)
MBZ is not just a tubulin inhibitor — it is a multi-tyrosine kinase inhibitor targeting BRAF (melanoma/colon driver), TNIK (Wnt/β-catenin activator), ABL1, and PDGFRA. This means MBZ simultaneously attacks multiple oncogenic drivers that cancer cells use to proliferate and resist treatment. A screening of 3,671 FDA-approved drugs specifically identified MBZ as a potent VEGFR2 inhibitor, and subsequent kinase binding assays confirmed it inhibits several additional kinases at nano- and micromolar concentrations
[PMID 31489501].
4. Reprograms Immune Cells to Attack (M1 Macrophage Polarization)
Tumors corrupt nearby immune cells (macrophages) into an immunosuppressive M2 phenotype that protects the tumor. MBZ reverses this — polarizing macrophages from pro-tumor M2 back to anti-tumor M1 phenotype. M1 macrophages actively destroy cancer cells and recruit additional immune effectors. Combined with IVM's immunogenic cell death (converting cold tumors hot), the two drugs create a comprehensive immune reprogramming effect
[PMID 31489501].
5. Starves Cancer Cells of Glucose (Metabolic Disruption)
MBZ was originally designed to prevent parasitic worms from absorbing sugar and nutrients — and this same mechanism applies to cancer. Cancer cells are heavily dependent on glucose (the Warburg effect) and microtubule-dependent intracellular transport for glucose uptake. MBZ's microtubule disruption impairs glucose transporter (GLUT) trafficking, while the closely related benzimidazole fenbendazole has been shown to directly inhibit GLUT transporter expression and hexokinase II — the key glycolytic enzyme cancer cells depend on
[PMID 30093705]. Combined with berberine's AMPK activation and glycolysis inhibition, and fasting's glucose deprivation, this protocol attacks cancer cell energy metabolism from three independent directions simultaneously.
⚡ Why They're More Powerful Together Than Apart
IVM attacks cancer's signaling (Akt/mTOR, WNT, PAK1) and defenses (P-gp drug resistance, immune evasion). MBZ attacks cancer's structure (microtubules), blood supply (VEGFR2), and energy (glucose metabolism). Cancer cells cannot simultaneously develop resistance to both structural destruction AND signaling shutdown. IVM's P-gp inhibition makes MBZ penetrate cancer cells more effectively. MBZ's immune reprogramming (M1 macrophages) combines with IVM's immunogenic cell death (T-cell recruitment) to create a comprehensive anti-tumor immune response. This is why the combined IVM + MBZ approach shows a 75% response rate across all cancer types in 480+ documented case reports.
📚 IVM & MBZ Anti-Cancer Mechanism Research:
📄
PubMed 27302166 — IVM induces cytostatic autophagy by blocking PAK1/Akt axis in breast cancer
📄
PubMed 32971268 — IVM: comprehensive anti-cancer review via PAK1, Akt/mTOR, WNT, STAT3, P-gp
📄
PubMed 25646014 — IVM blocks WNT-TCF pathway, eliminates cancer stem cell spheroids in colon cancer
📄
PubMed 27771251 — IVM induces mitochondrial dysfunction and oxidative stress in glioblastoma
📄
PubMed 28818736 — IVM targets renal cancer through mitochondrial dysfunction and oxidative damage
📄
PubMed 33493461 — IVM reverses P-glycoprotein multidrug resistance in cancer cells
📄
PubMed 33649334 — IVM + anti-PD1 synergistic complete tumor regression via immunogenic cell death
📄
PubMed 20644115 — IVM induces chloride-dependent membrane hyperpolarization and cell death in leukemia
📄
PubMed 33254747 — MBZ disrupts tubulin polymerization, G2/M arrest, apoptosis in cancer
📄
PubMed 31489501 — MBZ comprehensive oncology review: tubulin, VEGFR2, BRAF, TNIK, M1 macrophage polarization
📄
PubMed 25253417 — MBZ inhibits VEGFR2 kinase and tumor angiogenesis in medulloblastoma
📄
PubMed 30093705 — Benzimidazole (FBZ) inhibits glucose uptake, GLUT transporters, and hexokinase II in cancer
📄
PubMed 29280015 — IVM selectively induces apoptosis in CML via mitochondrial oxidative stress
📄
PubMed 32021111 — IVM antitumour mechanisms review: PAK1, WNT, Hippo, Akt/mTOR, chloride channels, ICD
🔬 ADVANCED & EMERGING THERAPIES
Cutting-edge treatments that may be available depending on your cancer type, location, and medical team. These represent the frontier of cancer medicine.
🧬 CAR-T Cell Therapy
CAR-T (Chimeric Antigen Receptor T-cell) therapy is a revolutionary immunotherapy where your own T-cells are extracted, genetically engineered to recognize and destroy your specific cancer cells, then infused back into your body. Six CAR-T products are now FDA-approved for blood cancers including B-cell acute lymphoblastic leukemia, large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, chronic lymphocytic leukemia, and multiple myeloma.
Published Outcomes:
•
Large B-cell lymphoma: CAR-T improved 4-year overall survival to 54.6% vs 46.0% with standard chemo + stem cell transplant (JAMA 2024)
•
Pediatric ALL: Emily Whitehead, the first pediatric CAR-T patient in 2012, remains cancer-free 12+ years later (CHOP)
•
Follicular lymphoma: axi-cel (Yescarta) eliminated cancer in nearly 80% of patients, with many still disease-free at 3 years (NCI)
•
Multiple myeloma: Phase II trial showed 97% overall response rate, 68% complete response, 95% alive at 12 months (MD Anderson, ASH 2025)
•
Large B-cell lymphoma: Over 30% of patients alive with zero evidence of cancer at 5 years post-treatment (NCI)
Key Considerations:
CAR-T is currently most effective for blood cancers (leukemias, lymphomas, myeloma). Solid tumor applications are in early clinical trials. Side effects can include cytokine release syndrome (CRS) and neurological effects, both manageable in specialized centers. CAR-T costs $373,000–$475,000 per treatment in the US but is covered by many insurance plans. Lasting remission rates range from 30–40% across all patients, but can be much higher for specific cancers.
🇨🇦 Alberta Health Coverage:
CAR-T cell therapy is available in Alberta through Alberta Health Services. The Made-in-Alberta CAR-T clinical trial at the Cross Cancer Institute (Edmonton) and Tom Baker Cancer Centre (Calgary) is funded by a $10-million Government of Alberta investment plus a $5-million Alberta Cancer Foundation grant. Approximately
80% of patients in these trials have seen their cancers significantly diminish or are in long-term remission. Commercial CAR-T products are also offered at Tom Baker Cancer Centre. Alberta became the third province to offer CAR-T therapy. Ontario, Quebec, and BC also fund CAR-T publicly. Patients in unfunded provinces may access treatment through out-of-province programs.
Don Goss — Alberta CAR-T Patient
Made-in-Alberta CAR-T trial, Cross Cancer Institute, Edmonton
After relapsing from two years of chemotherapy for acute lymphoblastic leukemia, Don made the difficult decision to enter hospice care. "That very same day, I was offered the chance to enter the new CAR-T trial. This new, revolutionary treatment has saved my life."
Source: Alberta Health Services
🫧 EBOO — Extracorporeal Blood Oxygenation & Ozonation
EBOO is an advanced form of ozone therapy where blood is drawn from one arm, passed through a dialysis-style filter that infuses it with medical-grade ozone and oxygen, then returned through the other arm. Unlike standard ozone autohemotherapy (which treats ~250ml), EBOO can treat up to 4,800ml of blood in a single 60-minute session — making it significantly more powerful
[PMID 16156950].
Why EBOO Matters for Cancer Fighters:
•
Oxygenation: Cancer cells thrive in low-oxygen environments (the Warburg effect). EBOO dramatically increases blood oxygen levels, creating conditions unfavorable for cancer growth
•
Immune activation: Ozone stimulates cytokine production and activates immune cells — enhancing the body's natural anti-tumor surveillance
•
Detoxification: The filtration process physically removes toxins, heavy metals, and metabolic waste from the blood — critical during or after chemotherapy
•
Reduced inflammation: Ozone has documented anti-inflammatory properties via NRF2 pathway activation
•
Enhanced drug delivery: Improved blood flow and oxygenation may improve the delivery and effectiveness of other treatments
Clinical Context:
EBOO has been used in over 2,000 published studies across Europe, Asia, and Latin America. It is offered at integrative oncology clinics as a complementary therapy alongside conventional or natural treatment. Sessions typically run weekly for 4–8 weeks, then monthly for maintenance. A G6-PD lab test is required before first session. EBOO is available at many of the integrative clinics listed below.
🫧 Top EBOO Clinics by Region
The following clinics are recognized for offering EBOO (Extracorporeal Blood Oxygenation & Ozonation) therapy. EBOO is the most advanced form of ozone therapy available — one session treats up to 2 liters of blood (compared to ~250ml with standard autohemotherapy). Always verify current availability, pricing, and practitioner credentials before booking.
🇨🇦 Canada
•
Nardella Clinic — Calgary, AB (20+ years integrative medicine, EBOO, ozone, HBOT, IV therapy, peptides, functional diagnostics) —
(403) 282-4488
•
Integrative Naturopathic Medical Centre — Vancouver, BC (EBOO, 10-pass ozone, IV vitamin C, regenerative injection therapy) —
integrative.ca
•
Emerald Medical & Wellness Centre — Edmonton, AB (Hyperbaric 10-pass ozone, MAH, HiDose O3, IV ozone specialists)
•
MedHelp Clinics — Toronto, ON (EBOO Full Spectrum with UBI, IV therapy, wellness optimization) —
medhelpclinics.com
🇺🇸 United States
•
Cancer Center for Healing — Irvine, CA (Dr. Leigh Erin Connealy — largest integrative cancer center in North America, EBOO, hyperthermia, IV-C)
•
AsandraMD — Beverly Hills & Newport Beach, CA (top-rated EBOO + UV light therapy, regenerative medicine, peptides)
•
Venturis Clinic — Oklahoma City, OK (Midwest EBOO leader, Weber Laser Needle technology, Harvard Pump system)
•
Extension Health — New York City (EBOO + UV therapy, plasma exchange, peptide therapy, longevity medicine)
•
The Blend Institute — Bradenton, FL (one of first US clinics to offer EBOO, full integrative medicine)
•
Sterling Family Practice — Sterling, VA (one of few EBOO providers in Virginia, MAH + UV therapy)
•
EBOO Clinic — Houston, TX (dedicated EBOO center, dialysis-style filtration, chronic illness focus)
•
American Regenerative Clinic — Various US locations (prolozone, multi-pass, and EBOO ozone therapy)
•
All Naturopathic Clinic — Beaverton, OR (EBOO with filtration, naturopathic oncology support)
•
Next Health — Multiple US locations (EBOO, therapeutic plasma exchange, NAD+, longevity protocols)
🇲🇽 Mexico
Mexico is a leading medical tourism destination for EBOO — world-class treatment at a fraction of US prices (typically $100–$300/session vs $500–$1,500 in the US/Canada).
•
PrecisionBio Clinic — Tijuana (Del Prado Medical Tower — integrative & regenerative medicine, US-standard sterilization, closed-loop EBOO, minutes from US border)
•
Holistic Care Clinic — Tijuana (EBOO, 10-pass ozone, free shuttle from San Diego border/airport, English-speaking staff) —
1 (619) 365-9003
•
Immunity Therapy Center — Tijuana (integrative cancer program, 10-pass ozone, stem cells, detox protocols)
•
Renovo Health & Beauty — Tijuana (EBOO, 30+ years medical experience, travel accommodations provided, 15 min from US border)
🇪🇺 Europe
Ozone therapy originated in Europe and has been practiced there for 100+ years. Germany, Switzerland, and Italy are global leaders in medical ozone research.
•
IV Drip Clinic — London, UK (EBOO + UV therapy, Long COVID recovery, immune support — one of UK’s leading EBOO providers)
•
Leicester Ozone Clinic — Leicester, UK (original German MAH technique, Midlands ozone specialists)
•
CLNQ — Manchester, UK (ozone therapy available now, EBO2/EBOO launching 2026, CQC registered)
•
Swiss Health Clinic — Frankfurt, Germany (ozone therapy, holistic healing, autohemotherapy — German/Swiss medical standards)
•
Blue Medical Center — Italy (oxygen-ozone therapy since 1983, Italian Society of Ozone Therapy affiliated)
•
Villa Medica — Edenkoben, Germany (pioneer in biological medicine, advanced ozone and oxidative therapies since the 1990s)
📋 EBOO Directory
•
TijuanaEBOOClinics.com — Curated directory of EBOO providers in Tijuana, Mexico
💡 Tip: Always ask clinics about: G6-PD testing requirement, number of recommended sessions, whether they use closed-loop systems, cost per session, and whether they offer EBOO+UBI (UV blood irradiation) combination therapy for enhanced results. Prices typically range from $100–$300 (Mexico), $500–$1,500 (USA), £1,490–£2,100 (UK), and vary across Europe.
🧴 Topical Ivermectin — For Skin Cancer & Rosacea
Beyond its systemic anti-cancer properties, ivermectin has emerging evidence for topical application directly on skin cancers. IVM cream (1%) is already FDA-approved for rosacea (brand name: Soolantra), where clinical trials demonstrated it is superior to metronidazole 0.75% for reducing inflammatory lesions with near-complete treatment response.
Skin Cancer Applications:
• IVM targets GSDMD (gasdermin D) to suppress neutrophil extracellular traps (NETs) that drive melanoma metastasis
[PMID 36139337]
• Macrocyclic lactones (the drug class including IVM) block melanoma growth, reduce pulmonary metastasis in mouse models, and potentiate BRAF V600 inhibitor activity — effective in both BRAF-wild-type AND BRAF-mutated melanomas (
Pharmacol Res 2016)
• Growing case reports from Canadian oncologist Dr. William Makis document topical IVM cream applied to basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) with photographic resolution of lesions over weeks
• One documented case: 63-year-old male with squamous cell lesion — applied ivermectin paste topically at bedtime daily for ~4 weeks — lesion completely resolved with clear skin and no scarring at 8-month follow-up
Rosacea:
• Randomized controlled trials confirm IVM 1% cream once daily is superior to metronidazole 0.75% twice daily for papulopustular rosacea
• IVM has dual anti-inflammatory and anti-parasitic action, targeting Demodex folliculorum (skin mites often involved in rosacea)
• Also effective for perioral dermatitis, cystic acne, and Demodex-related skin conditions
🩺 Follow Dr. William Makis MD, FRCPC
Education: BSc Immunology (University of Toronto, Governor General's Medal recipient) • MD (McGill University, 2005) • Specialty Residency in Nuclear Medicine (McGill)
Career: Nuclear Medicine Oncologist, PET/CT Lead & Theranostics Expert — Cross Cancer Institute, Edmonton, AB • Assistant Clinical Professor, Dept. of Radiology & Diagnostic Imaging, University of Alberta • Director of Nuclear Medicine, Brandon Regional Health Centre • Managed the largest single-institution Lutathera (¹⁷⁷Lu-DOTATATE) Phase II Clinical Trial in North America (250 neuroendocrine tumor patients)
Research: 115+ peer-reviewed publications (ResearchGate) • 1,343+ citations (Google Scholar) • 10,000+ cancer diagnoses via PET/CT • Published in Nature, Lancet, and leading nuclear medicine journals
Cancer Advocacy: Author of the world's largest ivermectin/fenbendazole/mebendazole cancer case report compilation (480+ documented cases as of Feb 2026)
💬 REAL TESTIMONIALS FROM CANCER FIGHTERS
These are real accounts from patients and their families, organized by the approach they chose. Every person's cancer and circumstances are different. These stories are shared to inform, not to guarantee outcomes.
🌿 Natural / Repurposed Drug Protocol
Joe Tippens — Stage 4 Non-Small Cell Lung Cancer
Natural protocol (fenbendazole + curcumin + CBD oil + Vitamin E)
Diagnosed in 2016 with non-small cell lung cancer with extensive metastatic disease. At the advice of a veterinarian friend, he took fenbendazole together with nanocurcumin. Three months after starting these compounds, his PET scan was completely clear. His story went viral and launched the "Joe Tippens Protocol" — now followed by thousands of cancer patients worldwide.
"My stomach, my neck, my liver, my pancreas, my bladder, my bones — it was everywhere. Once that kind of cancer goes that far afield, the odds of survival are less than 1 percent, and median life expectancy is three months."
"My insurance company spent $1.2 million on me with traditional means before I switched to a $5-a-week medicine that actually saved me."
"I've got over 40 success stories other than me. If I've saved one other person other than me, it's worth it to me."
Key detail: Tippens was the only patient cured among 1,100 in his clinical trial at MD Anderson Cancer Center. He was also enrolled in a Keytruda (immunotherapy) trial during this period. Joe credits fenbendazole and continues to take it daily as prevention. His Facebook community "My Cancer Story Rocks" now has 59,000+ members, and over 5,000 success stories have been documented globally. We present the full picture so you can decide what's right for you.
Source: KOCO News Oklahoma (2019) / mycancerstory.rocks / Dr. William Makis compilation
66-Year-Old Ontario Man — Glioblastoma (Unmethylated)
IVM + MBZ protocol alongside conventional chemo/radiation
"He recently had his first MRI since chemo and radiation begun — there were no abnormal changes, no abnormalities, no new artifacts. Overall, both our family and the oncologists were extremely happy to not see any visible growth or changes." Quoted a life expectancy as low as 6 months — cancer-free at 4 months on high-dose IVM + MBZ.
Source: Dr. William Makis, 2025
77-Year-Old — Stage 4 Pancreatic Cancer
IVM + Fenbendazole + MBZ protocol
99.9% drop in CA19-9 tumor marker levels and 70–87% shrinkage of tumors. Stage 4 pancreatic cancer is one of the most difficult diagnoses in all of oncology — these results stunned the treating oncologists.
Source: Dr. William Makis, April 2025
57-Year-Old Canadian Retired ICU Nurse — Stage 3C Ovarian Cancer
IVM + MBZ + CBD Oil protocol
"I started your alternative protocol end of January with mebendazole. I feel amazingly well, gained weight, lots of energy, walking 5 miles a day, lifting weights." NLR (inflammation marker) dropped from 11 to 1.2 in 4 months. "My hematologist is very enthusiastic about my progress. My GP cannot believe that I am so well — he said 'whatever you are doing, keep doing it!'" Her surgeon requested the research lab test her tumor against ivermectin and mebendazole.
Source: Dr. William Makis, 2025
81-Year-Old Woman in Shanghai — Stage 4 Melanoma
IVM (1mg/kg/day) + Fenbendazole (1000mg/day)
"We're seeing great remission of the tumor on her neck, a shrinkage of about 70%. We're very thrilled over the progress and very grateful!" After 3 months: "My aunt's stage 4 melanoma has been in remission since she started the protocol."
Source: Dr. William Makis, November 2025
64-Year-Old Canadian Woman — Stage 4 NSCLC with 20+ Brain Metastases
IVM (1.5mg/kg/day) + MBZ (2000mg/day)
After 2 months: brain lesion shrinkage of 65–90% across five measured metastases. Largest lesion shrank from 16x13mm to 10x7mm (80% reduction). This is shrinkage of brain metastases — one of the hardest locations to treat in all of oncology.
Source: Dr. William Makis, 2025
🔄 Combined: Natural Protocol + Conventional Treatment
Stage 4 Melanoma Patient — Immunotherapy + IVM
Added IVM to ongoing immunotherapy
"She was taking immunotherapy for about a year. Her lesions were having moderate response per PET scans. After putting her on ivermectin, 45 days later with a PET scan she presented cancer-free. We were blown away. I almost cried. Her last PET scan was approximately 6 months — she was cancer-free. Her oncologist was all smiles, but I never told him I was giving her the protocol."
Source: Dr. William Makis patient compilation
62-Year-Old — Head & Neck SCC with Lung Metastases
5 rounds chemo + 37 rounds radiation, then added IVM + MBZ
After conventional treatment failed to stop progression, added high-dose IVM and MBZ. Cancer-free after 2.5 months on the combined protocol. "For those who proceed with conventional chemotherapy or radiation therapy — you should know that you will get much better results combining with Ivermectin."
Source: Dr. William Makis, 2025
Husband with Squamous Cell Cancer of the Neck
IVM paste + fenbendazole alongside conventional care
"My husband was diagnosed in 2021 with squamous cell cancer in his neck. He had a mass surrounding his carotid artery — couldn't be removed because of the location. I stumbled upon the Joe Tippens protocol and got some ivermectin paste and fenbendazole. He continued with treatment alongside the use of this protocol. A few months later — no presence of any tumor. It completely vanished. After only four chemo treatments the doctor could not comprehend how the cancer managed to disappear like that, and so quickly."
Source: Patient testimonial via onedaymd.com
🧬 CAR-T Cell Therapy
Emily Whitehead — Pediatric ALL (First Child Ever Treated)
CAR-T cell therapy at Children's Hospital of Philadelphia, 2012
At age 6, Emily was near death — chemotherapy had failed, she was ineligible for bone marrow transplant, and her family was told to bring her home to die. She became the first child to receive CAR-T cell therapy under Dr. Stephan Grupp at CHOP. Within a month she achieved complete remission. As of 2024, Emily remains cancer-free — 12+ years later. Her treatment led directly to the first FDA-approved CAR-T product (Kymriah) in 2017.
Source: Children's Hospital of Philadelphia
Rich Gingerelli — Diffuse Large B-Cell Lymphoma
CAR-T at NewYork-Presbyterian/Columbia
After chemotherapy and a stem cell transplant both failed, Rich's doctors introduced him to CAR-T cell therapy. "This is the best thing that could ever have happened. For me, it worked a miracle." Two years cancer-free after a single CAR-T infusion. His wife: "Before the CAR T treatment, we were making plans for Rich to pass. I still get chills just talking about it."
Source: Herbert Irving Comprehensive Cancer Center, Columbia
Robyn Stacy-Humphries, MD — Triple-Relapsed DLBCL
CAR-T cell therapy, September 2016
A radiologist who relapsed three times from large B-cell lymphoma after chemotherapy and a stem cell transplant. Within 24 hours of CAR-T infusion: "the lymph nodes were half their size; within three days they were gone. It was like ice cubes melting." She titled her account: "CAR-T Cell Therapy Gave Me Back My Life."
Source: Association of Community Cancer Centers / HealthWell Foundation
DLBCL Patient — Six Years Cancer-Free
CAR-T at University of Chicago Medicine (first in Illinois)
After multiple rounds of chemotherapy, a stem cell transplant, two clinical trials, and targeted radiation all provided only temporary remission, he became the first CAR-T patient in Illinois. "CAR-T was our 'hail Mary' pass. We threw the ball up in the air, and it ended up being a touchdown." Still cancer-free 6+ years later. Rides his bicycle daily and attends Notre Dame football games.
Source: UChicago Medicine
🧴 Topical Ivermectin for Skin Cancer
63-Year-Old Male — Squamous Cell Carcinoma (Face)
Topical ivermectin paste applied daily at bedtime for ~4 weeks
Dermatologist recommended Mohs surgery. Instead, he applied ivermectin paste topically. "After about two weeks, the patch of skin became flakier and the redness decreased. After about a month, the patch had flaked off completely and the skin was clear." Photo at 8 months: "Looks like normal skin to me, without any scarring at all." No side effects.
Source: fenbendazole.substack.com, August 2023
Basal Cell Carcinoma — Resolution Before Scheduled Surgery
Topical IVM cream applied twice daily
Documented by Canadian oncologist Dr. William Makis: patient with biopsy-confirmed basal cell carcinoma on face applied topical ivermectin cream while waiting for surgical appointment. Photographic resolution of the lesion — "One cannot surgically remove a basal cell cancer that no longer exists." The patient may have to cancel his planned surgical removal.
Source: Dr. William Makis, December 2024
✝ God’s Promises of Healing
"For I know the plans I have for you," declares the LORD, "plans to prosper you and not to harm you, plans to give you hope and a future."
— Jeremiah 29:11 (NIV)
"Heal me, O Lord, and I shall be healed; save me, and I shall be saved: for thou art my praise."
— Jeremiah 17:14 (KJV)
"Bless the Lord, O my soul, and forget not all his benefits: Who forgiveth all thine iniquities; who healeth all thy diseases."
— Psalm 103:2-3 (KJV)
"For I will restore health to you, and your wounds I will heal, declares the Lord."
— Jeremiah 30:17 (ESV)
"The Lord sustains him on his sickbed; in his illness you restore him to full health."
— Psalm 41:3 (ESV)
"If you will diligently listen to the voice of the Lord your God, and do that which is right in his eyes, I will put none of the diseases on you that I put on the Egyptians, for I am the Lord, your healer."
— Exodus 15:26 (ESV)
"Who his own self bare our sins in his own body on the tree, that we, being dead to sins, should live unto righteousness: by whose stripes ye were healed."
— 1 Peter 2:24 (KJV)
"But unto you that fear my name shall the Sun of righteousness arise with healing in his wings."
— Malachi 4:2 (KJV)
"The Spirit of God, who raised Jesus from the dead, lives in you. And just as God raised Christ Jesus from the dead, he will give life to your mortal bodies by this same Spirit living within you."
— Romans 8:11 (NLT)
"No weapon that is formed against thee shall prosper."
— Isaiah 54:17 (KJV)
🏥 TOP CANCER TREATMENT CLINICS — By Approach
Whether you're pursuing a natural, integrative, or conventional path — or a combination — here are some of the most respected clinics in their respective fields. Always do your own research and consultation before choosing a treatment center.
🌿 Integrative & Functional Medicine Cancer Clinics
These clinics combine evidence-based natural therapies (high-dose IV vitamin C, hyperthermia, mistletoe, ozone therapy, metabolic approaches) with or alongside conventional treatments.
🇨🇦 Canada:
•
Integrated Health Clinic — Fort Langley, BC (Dr. Gurdev Parmar, ND — leader in hyperthermia + naturopathic oncology, selected for US-Canadian Integrative Oncology Outcomes Study)
•
CCNM Integrative Cancer Clinic — Toronto, ON (Canadian College of Naturopathic Medicine — collaborates with Cancer Care Ontario)
•
The Clara Clinic — Toronto, ON (Drs. Hayhlee Clarence & Monica Velletri, ND — specialized integrative cancer care)
•
Vital Victoria Naturopathic Clinic — Victoria, BC (naturopathic oncology focus)
•
Canadian Naturopathic Cancer Clinic — Oakville, ON (naturopathic oncology + IV therapies)
•
Timeless Health Clinic (Lumèr) — Toronto, ON (high-dose IV-C, mistletoe therapy, holistic cancer care)
•
Village Centre for Integrative Medicine — Toronto, ON (IV therapies, detox, naturopathic oncology)
•
Dr. LaValley MD — Ottawa, ON (personalized anti-cancer protocol using repurposed drugs + supplements)
•
Insight Naturopathic — Toronto, ON (Drs. Fontes, Shainhouse, Tayebi — IV-C, mistletoe, integrative oncology)
•
Boucher Naturopathic Clinic — New Westminster, BC (teaching clinic with naturopathic oncology)
🇺🇸 United States:
•
Cancer Center for Healing — Irvine, CA (Dr. Leigh Erin Connealy — largest integrative cancer center in North America, EBOO, hyperthermia, IV-C)
•
Brio-Medical Cancer Clinic — Scottsdale, AZ (full integrative oncology program, EBOO, all stages/types)
•
Envita Medical Center — Scottsdale, AZ (genomic medicine, dendritic cell therapy, IPT, complex late-stage cases)
•
Oasis of Healing — Mesa, AZ (Dr. Thomas Lodi — metabolic approach, IPT low-dose chemo, IV therapies)
•
Dr. Nasha Winters — Colorado (consultant — metabolic approach to cancer, mistletoe pioneer, author of "The Metabolic Approach to Cancer")
•
Integrative Health Care — Scottsdale, AZ (Dr. Alan Christianson, ND — metabolic therapies, IV nutrition)
•
New Hope Unlimited — Scottsdale, AZ (residential program, IV therapy, detox, immune support for Stage 3-4)
•
Immunotherapy Institute — Baja California, Mexico/US border (integrative immunotherapy, natural cancer care)
•
Seattle Integrative Cancer Center — Seattle, WA (Dr. Nick Chen, MD, PhD — integrative oncology + hyperthermia)
•
Whole Health Houston — Houston, TX (EBOO ozone therapy, integrative cancer support)
🇲🇽 Mexico (Popular with North American Patients):
Mexico has become a destination for integrative cancer treatment due to access to therapies not yet available in the US/Canada, often at lower cost.
•
Hope4Cancer Treatment Centers — Tijuana, MX (sono-photo dynamic therapy, Sunivera bio-immunotherapy, 7 Key Principles approach — patients from 100+ countries, 50+ states. "The treatment program was the most comprehensive approach I had ever seen — detoxify, boost the immune system, and address the emotional side. Soon the cancer was completely gone.")
•
Oasis of Hope Hospital — Tijuana, MX (50+ years experience, founded by Dr. Contreras, integrative oncology + emotional/spiritual support, over 100,000 patients treated)
•
Sanoviv Medical Institute — Rosarito Beach, MX (luxury integrative medical center, comprehensive diagnostic workup, LEED-certified organic facility)
•
CHIPSA Hospital — Tijuana, MX (Gerson therapy pioneer, immunotherapy, integrative protocols — one of the oldest alternative cancer treatment facilities)
•
BioCare Hospital & Wellness Center — Tijuana, MX (biological medicine, dendritic cell therapy, hyperthermia)
•
CMN Hospital — Tijuana, MX (alternative cancer treatment, metabolic therapies)
•
ITC — Immunity Therapy Center — Tijuana, MX (personalized immunotherapy, non-toxic treatments)
•
Williams Cancer Institute — Tijuana, MX & Thailand (Dr. Jason Williams — intratumoral immunotherapy, cryoablation, checkpoint inhibitor injection directly into tumors)
•
Dr. Castillo's CIPAG Clinic — Tijuana, MX (35+ years experience, 15,000+ patients since 1991, metabolic therapy, high-dose IV vitamin C, DMSO, laetrile, chelation, Hoxsey-style herbals. Trained under Dr. Contreras Sr. at Oasis of Hope + Gerson Clinic. Very popular with Albertans and Canadians. Affordable: $5,000–$9,000 for 21-day program. "This place saved me... No chemo, no radiation... just diet treatment and supplements. I'm very thankful we found this place." — 2025 patient review. "The best decision ever made for me to go to Dr. Castillo's clinic. The clinic saved my life. I have outlived anything conventional medicine could have done for me." — Stage 4 patient)
•
San Diego Clinic — Tijuana, MX (Dr. Munoz — autologous therapies, cancer vaccines, IPT, high-dose IV-C, personalized protocols, extensive home care program with at-home IVs)
•
Integrative Whole Health Clinic — Tijuana, MX (Dr. Henriquez — hyperthermia specialist, stem cell, dendritic cell therapy, 1:1 care with head doctor)
•
Immunocine — Tijuana, MX (cutting-edge immunotherapy, personalized cancer vaccine protocols)
🇪🇺 Europe:
•
Arcadia Clinic — Bad Emstal, Germany (integrative oncology, hyperthermia, biological medicine — Germany is the global leader in integrative cancer care)
•
Hufeland Clinic — Bad Mergentheim, Germany (holistic cancer care, decades of experience)
•
Marinus am Stein — Brannenburg, Germany (integrative medicine, biological cancer therapies)
•
Hallwang Clinic — Schwanau, Germany (personalized immunotherapy, dendritic cell therapy, hyperthermia)
•
Paracelsus Clinic — Lustmühle, Switzerland (biological medicine, comprehensive diagnostics, dental focus)
•
Infusio — Frankfurt, Germany & Beverly Hills, CA (advanced cell therapy, regenerative medicine)
•
Medical Center Cologne — Cologne, Germany (regional hyperthermia, insulin potentiation therapy, IV therapies)
•
Dove Clinic — Twyford, Hampshire, UK (integrative cancer support, IV vitamin C, mistletoe)
•
Budwig Center — Malaga, Spain (Dr. Johanna Budwig protocol — flaxseed oil/cottage cheese, hyperthermia, bio-resonance)
•
Biomedic Clinic — Vilnius, Lithuania (integrative cancer treatment, hyperthermia, affordable European option)
🏛️ Top Conventional Cancer Centers (Surgery, Chemo, Radiation, CAR-T)
If you choose conventional treatment, go to the best. These are internationally ranked cancer centers with the highest survival rates, clinical trial access, and CAR-T programs.
🇨🇦 Canada:
•
Princess Margaret Cancer Centre — Toronto, ON (consistently ranked top 5 globally, major clinical trial hub)
•
BC Cancer — Vancouver, BC (comprehensive provincial cancer program, world-class research)
•
Cross Cancer Institute — Edmonton, AB (Alberta's primary cancer treatment and research center)
•
Tom Baker Cancer Centre — Calgary, AB (Alberta Health Services — comprehensive cancer care)
•
The Ottawa Hospital Cancer Centre — Ottawa, ON (strong immunotherapy and clinical trial programs)
•
Juravinski Cancer Centre — Hamilton, ON (Hamilton Health Sciences — radiation oncology excellence)
•
McGill University Health Centre — Montreal, QC (Cedars Cancer Centre — surgical oncology leader)
•
CancerCare Manitoba — Winnipeg, MB (comprehensive cancer services for Central Canada)
•
QEII Health Sciences Centre — Halifax, NS (Atlantic Canada's primary cancer center)
•
Sunnybrook Odette Cancer Centre — Toronto, ON (leading radiation oncology, Gamma Knife)
🇺🇸 United States:
•
MD Anderson Cancer Center — Houston, TX (consistently #1 ranked, largest cancer center in the world, CAR-T pioneer)
•
Memorial Sloan Kettering (MSK) — New York, NY (top-ranked, massive clinical trial portfolio)
•
Mayo Clinic — Rochester, MN / Phoenix, AZ / Jacksonville, FL (multi-site, known for complex cases + second opinions)
•
Dana-Farber Cancer Institute — Boston, MA (Harvard-affiliated, immunotherapy leader)
•
Johns Hopkins Sidney Kimmel Cancer Center — Baltimore, MD (immunotherapy pioneer — checkpoint inhibitors originated here)
•
City of Hope — Duarte, CA (CAR-T expertise, bone marrow transplant pioneer)
•
Fred Hutchinson Cancer Center — Seattle, WA (bone marrow transplant + CAR-T pioneer, immunotherapy leader)
•
UCSF Helen Diller Cancer Center — San Francisco, CA (brain tumor expertise, precision medicine)
•
Cleveland Clinic Cancer Center — Cleveland, OH (NCI-designated, surgical excellence)
•
Moffitt Cancer Center — Tampa, FL (NCI-designated comprehensive cancer center, immunotherapy focus)
🇪🇺 Europe:
•
Gustave Roussy — Villejuif, France (Europe's largest cancer center, clinical trial leader)
•
The Christie — Manchester, UK (largest single-site cancer center in Europe, proton beam therapy)
•
The Royal Marsden — London, UK (world's first dedicated cancer hospital, immunotherapy pioneer)
•
Charité Comprehensive Cancer Center — Berlin, Germany (university hospital, CAR-T program)
•
Netherlands Cancer Institute (NKI) — Amsterdam, Netherlands (research-driven, personalized oncology)
•
Karolinska University Hospital — Stockholm, Sweden (Nobel Prize institution, cutting-edge research)
•
Istituto Europeo di Oncologia (IEO) — Milan, Italy (surgical oncology, minimally invasive techniques)
•
Vall d'Hebron Institute of Oncology (VHIO) — Barcelona, Spain (major clinical trial site, precision oncology)
•
University Hospital Zurich — Zurich, Switzerland (comprehensive oncology, proton therapy)
•
Heidelberg University Hospital / NCT — Heidelberg, Germany (National Center for Tumor Diseases — heavy-ion therapy, precision oncology)
"Is anyone among you sick? Let him call for the elders of the church, and let them pray over him, anointing him with oil in the name of the Lord. And the prayer of faith will save the sick, and the Lord will raise him up."
— James 5:14-15 (NKJV)
"Have I not commanded you? Be strong and of good courage; do not be afraid, nor be dismayed, for the LORD your God is with you wherever you go."
— Joshua 1:9 (NKJV)
"And God shall wipe away all tears from their eyes; and there shall be no more death, neither sorrow, nor crying, neither shall there be any more pain: for the former things are passed away."
— Revelation 21:4 (KJV)
"And the leaves of the tree were for the healing of the nations."
— Revelation 22:2 (KJV)
You found this protocol for a reason. God placed every herb on this earth, designed your immune system to destroy cancer, and led you here. Never give up. Choose life. Choose hope.
